Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + LMB Chemotherapy in Burkitt Lymphoma
NCT00180882Phase 3Unknown
- Sponsor
- Gustave Roussy
- Start
- Oct 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in Burkitt lymphoma (BL), acute lymphoblastic leukemia (ALL), sponsored by Gustave Roussy. Status: unknown.
02
Drugs
rituximab
03
Conditions
Burkitt lymphoma (BL)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00180882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180882.